SandraHaefnerBignerMD
Pathology • Burlington, NCCytopathology, Neuropathology, Anatomic Pathology, Clinical Pathology
Physician
Are you Dr. Bigner?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2039 Willow Spring Ln
Burlington, NC 27215Phone+1 336-436-6122Fax+1 336-436-6125
Summary
- Dr. Sandra Bigner, MD is a board certified pathologist in Burlington, North Carolina. She is currently licensed to practice medicine in North Carolina, Maryland, and Georgia.
Education & Training
Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1975 - 1975- Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1973 - 1974
- Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1972 - 1972
University of Tennessee Health Science Center College of MedicineClass of 1971
Certifications & Licensure
VA State Medical License 2006 - 2024
GA State Medical License 2006 - 2023
NC State Medical License 1975 - 2023
SC State Medical License 1998 - 2023
TN State Medical License 2006 - 2023
MD State Medical License 2009 - 2022- American Board of Pathology Anatomic Pathology
- American Board of Pathology Cytopathology
- American Board of Pathology Neuropathology
Publications & Presentations
PubMed
- 3896 citationsPTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerJing Li, Clifford Yen, Danny Liaw, Katrina Podsypanina, Shikha Bose
Science. 1997-03-28 - 31 citationsComprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft.Naji Aldosari, Rodney N. Wiltshire, Amalia Dutra, Evelin Schröck, Roger E. McLendon
Neuro-Oncology. 2002-04-01 - 93 citationsClinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia.Michael J. Borowitz, Jon P. Gockerman, Joseph O. Moore, Curt I. Civin, Stella O. Page
American Journal of Clinical Pathology. 1989-03-01
Grant Support
- Growth Control And Cytogenetics Of Malignant GliomasNational Cancer Institute1987–2003
- Core--Tissue Procurement And CytogeneticsNational Cancer Institute1999–2002
- Molecular Markers Of Prognosis In MedulloblastomaNational Cancer Institute1996–2000
- Core--Human Tissue Bank And CytogeneticsNational Cancer Institute1996–1999
- Tumor Suppressor Genes In Human MedulloblastomaNational Institute Of Neurological Disorders And Stroke1996–1998
- Growth Control And Cytogenetics Of Malignant GliomasNational Cancer Institute1991–1998
